{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:07:05Z","timestamp":1791328025314,"version":"4.3.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T00:00:00Z","timestamp":1366848000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s11010-013-1671-1","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T22:40:54Z","timestamp":1367361654000},"page":"177-184","source":"Crossref","is-referenced-by-count":30,"title":["Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by \u03b1v\u03b26 integrin-mediated signaling in ovarian cancer"],"prefix":"10.1007","volume":"380","author":[{"given":"Baoyao","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuecheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,25]]},"reference":[{"key":"1671_CR1","doi-asserted-by":"crossref","unstructured":"Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A (1989) Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science (New York, NY) 244(4905):707","DOI":"10.1126\/science.2470152"},{"issue":"5","key":"1671_CR2","first-page":"355","volume":"5","author":"H Naora","year":"2005","unstructured":"Naora H, Montell DJ (2005) Ovarian cancer metastasis: integrating insights from disparate model organisms. Mol Cell Biochem 5(5):355\u2013366","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1671_CR3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52\u201367","journal-title":"Cell"},{"issue":"10","key":"1671_CR4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","volume":"5","author":"W Guo","year":"2004","unstructured":"Guo W, Giancotti FG (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5(10):816\u2013826","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1671_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02967183","volume":"7","author":"K Arihiro","year":"2000","unstructured":"Arihiro K, Kaneko M, Fujii S, Inai K, Yokosaki Y (2000) Significance of \u03b19\u03b21 and \u03b1v\u03b26 integrin expression in breast carcinoma. Breast Cancer 7(1):19\u201326","journal-title":"Breast Cancer"},{"key":"1671_CR6","doi-asserted-by":"crossref","unstructured":"Yue J, Zhang K, Chen JF (2012) Role of integrins in regulating proteases to mediate extracellular matrix remodeling. Cancer Microenviron 5(3):1\u20139","DOI":"10.1007\/s12307-012-0101-3"},{"issue":"18","key":"1671_CR7","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1158\/0008-5472.CAN-12-0634","volume":"72","author":"AF Hezel","year":"2012","unstructured":"Hezel AF, Deshpande V, Zimmerman SM, Contino G, Alagesan B, O\u2019Dell MR, Rivera LB, Harper J, Lonning S, Brekken RA (2012) TGF-\u03b2 and \u03b1v\u03b26 integrin act in a common pathway to suppress pancreatic cancer progression. Cancer Res 72(18):4840\u20134845","journal-title":"Cancer Res"},{"key":"1671_CR8","doi-asserted-by":"crossref","unstructured":"Yang SB, Du Y, Wu BY, Xu SP, Wen JB, Zhu M, Cai CH, Yang PC (2012) Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer. Cancer Immunol Immunother 61(3):335\u2013342","DOI":"10.1007\/s00262-011-1108-1"},{"key":"1671_CR9","doi-asserted-by":"crossref","unstructured":"Eberlein C, Kendrew J, McDaid K, Alfred A, Kang J, Jacobs V, Ross S, Rooney C, Smith N, Rinkenberger J (2012) A human monoclonal antibody 264RAD targeting \u03b1v\u03b26 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo. Oncogene","DOI":"10.1038\/onc.2012.460"},{"issue":"6","key":"1671_CR10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1523-1747.2001.01352.x","volume":"116","author":"GJ Thomas","year":"2001","unstructured":"Thomas GJ, Poomsawat S, Lewis MP, Hart IR, Speight PM, Marshall JF (2001) \u03b1v\u03b26 integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Dermatol 116(6):898\u2013904","journal-title":"J Invest Dermatol"},{"issue":"3","key":"1671_CR11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/path.2168","volume":"212","author":"S Hazelbag","year":"2007","unstructured":"Hazelbag S, Kenter G, Gorter A, Dreef E, Koopman L, Violette S, Weinreb P, Fleuren G (2007) Overexpression of the \u03b1v\u03b26 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival. J Pathol 212(3):316\u2013324","journal-title":"J Pathol"},{"issue":"7","key":"1671_CR12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2174\/138945009788680374","volume":"10","author":"A Bandyopadhyay","year":"2009","unstructured":"Bandyopadhyay A, Raghavan S (2009) Defining the role of integrin \u03b1v\u03b26 in cancer. Curr Drug Targets 10(7):645","journal-title":"Curr Drug Targets"},{"issue":"11","key":"1671_CR13","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP (2010) CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin Cancer Res 16(11):2927\u20132931","journal-title":"Clin Cancer Res"},{"issue":"16","key":"1671_CR14","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-10-3143","volume":"71","author":"E Righi","year":"2011","unstructured":"Righi E, Kashiwagi S, Yuan J, Santosuosso M, Leblanc P, Ingraham R, Forbes B, Edelblute B, Collette B, Xing D (2011) CXCL12\/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res 71(16):5522\u20135534","journal-title":"Cancer Res"},{"issue":"3","key":"1671_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ncb1838","volume":"11","author":"JM Gillette","year":"2009","unstructured":"Gillette JM, Larochelle A, Dunbar CE, Lippincott-Schwartz J (2009) Intercellular transfer to signalling endosomes regulates an ex vivo bone marrow niche. Nat Cell Biol 11(3):303\u2013311","journal-title":"Nat Cell Biol"},{"issue":"12","key":"1671_CR16","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1164\/rccm.200301-071OC","volume":"167","author":"RJ Phillips","year":"2003","unstructured":"Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM (2003) The stromal derived factor-1\/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167(12):1676\u20131686","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"1671_CR17","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1158\/0008-5472.CAN-03-3958","volume":"64","author":"Z Liang","year":"2004","unstructured":"Liang Z, Wu T, Lou H, Yu X, Taichman RS, Lau SK, Nie S, Umbreit J, Shim H (2004) Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64(12):4302\u20134308","journal-title":"Cancer Res"},{"issue":"6824","key":"1671_CR18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A M\u00fcller","year":"2001","unstructured":"M\u00fcller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50\u201356","journal-title":"Nature"},{"issue":"1","key":"1671_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/pros.20500","volume":"67","author":"YX Sun","year":"2006","unstructured":"Sun YX, Fang M, Wang J, Cooper CR, Pienta KJ, Taichman RS (2006) Expression and activation of \u03b1v\u03b23 integrins by SDF-1\/CXC12 increases the aggressiveness of prostate cancer cells. Prostate 67(1):61\u201373","journal-title":"Prostate"},{"issue":"3","key":"1671_CR20","doi-asserted-by":"crossref","first-page":"C987","DOI":"10.1152\/ajpcell.00406.2006","volume":"292","author":"I Kryczek","year":"2007","unstructured":"Kryczek I, Wei S, Keller E, Liu R, Zou W (2007) Stroma-derived factor (SDF-1\/CXCL12) and human tumor pathogenesis. Am J Physiol Cell Physiol 292(3):C987\u2013C995","journal-title":"Am J Physiol Cell Physiol"},{"issue":"20","key":"1671_CR21","first-page":"5930","volume":"62","author":"CJ Scotton","year":"2002","unstructured":"Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G, Balkwill FR (2002) Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62(20):5930\u20135938","journal-title":"Cancer Res"},{"issue":"5","key":"1671_CR22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/01.cej.0000236259.88146.a4","volume":"16","author":"Y Yuecheng","year":"2007","unstructured":"Yuecheng Y, Xiaoyan X (2007) Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2. Eur J Cancer Prev 16(5):430\u2013435","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"1671_CR23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood-2003-08-2661","volume":"104","author":"E Benasciutti","year":"2004","unstructured":"Benasciutti E, Pag\u00e8s G, Kenzior O, Folk W, Blasi F, Crippa MP (2004) MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood 104(1):256\u2013262","journal-title":"Blood"},{"issue":"4","key":"1671_CR24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2353\/ajpath.2009.080160","volume":"174","author":"MY Xu","year":"2009","unstructured":"Xu MY, Porte J, Knox AJ, Weinreb PH, Maher TM, Violette SM, McAnulty RJ, Sheppard D, Jenkins G (2009) Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Am J Pathol 174(4):1264\u20131279","journal-title":"Am J Pathol"},{"issue":"36","key":"1671_CR25","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1038\/sj.onc.1205646","volume":"21","author":"SS Lakka","year":"2002","unstructured":"Lakka SS, Jasti SL, Gondi C, Boyd D, Chandrasekar N, Dinh DH, Olivero WC, Gujrati M, Rao JS (2002) Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21(36):5601\u20135608","journal-title":"Oncogene"},{"issue":"1","key":"1671_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0714.2005.00374.x","volume":"35","author":"G Thomas","year":"2006","unstructured":"Thomas G, Nystr\u00f6m M, Marshall J (2006) \u03b1v\u03b26 integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med 35(1):1\u201310","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"1671_CR27","first-page":"1","volume":"2","author":"DA Stewart","year":"2004","unstructured":"Stewart DA, Cooper CR, Sikes RA (2004) Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod Biol Endocrinol 2(2):1\u201313","journal-title":"Reprod Biol Endocrinol"},{"issue":"9","key":"1671_CR28","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1084\/jem.20052144","volume":"203","author":"JM Burns","year":"2006","unstructured":"Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold MET, Sunshine MJ, Littman DR, Kuo CJ (2006) A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203(9):2201\u20132213","journal-title":"J Exp Med"},{"issue":"5430","key":"1671_CR29","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","volume":"285","author":"FG Giancotti","year":"1999","unstructured":"Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285(5430):1028\u20131033","journal-title":"Science"},{"issue":"5570","key":"1671_CR30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1126\/science.1067431","volume":"296","author":"BS Wiseman","year":"2002","unstructured":"Wiseman BS, Werb Z (2002) Stromal effects on mammary gland development and breast cancer. Science 296(5570):1046\u20131049","journal-title":"Science"},{"issue":"7","key":"1671_CR31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev Cancer 2(7):489\u2013501","journal-title":"Nat Rev Cancer"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-013-1671-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-013-1671-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-013-1671-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T06:44:31Z","timestamp":1563000271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-013-1671-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,25]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1007\/s11010-013-1671-1","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,25]]}}}